Molecular Imaging Biomarkers for Oncology Clinical Trials

被引:55
作者
Mankoff, David A. [1 ]
Pryma, Daniel A. [1 ]
Clark, Amy S. [2 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
关键词
cancer biomarkers; clinical trials; cancer therapy; BREAST-CANCER; FDG-PET; TRASTUZUMAB; CRITERIA;
D O I
10.2967/jnumed.113.126128
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.
引用
收藏
页码:525 / 528
页数:4
相关论文
共 50 条
  • [31] Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
    Fontana, E.
    Eason, K.
    Cervantes, A.
    Salazar, R.
    Sadanandam, A.
    ANNALS OF ONCOLOGY, 2019, 30 (04) : 520 - 527
  • [32] Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings
    Azari, Feredun
    Kennedy, Gregory
    Bernstein, Elizabeth
    Hadjipanayis, Constantinos
    Vahrmeijer, Alexander L.
    Smith, Barbara L.
    Rosenthal, Eben
    Sumer, Baran
    Tian, Jie
    Henderson, Eric R.
    Lee, Amy
    Quyen Nguyen
    Gibbs, Summer L.
    Pogue, Brian W.
    Orringer, Daniel A.
    Charalampaki, Cleopatra
    Martin, Linda W.
    Tanyi, Janos L.
    Lee, Major Kenneth
    Lee, John Y. K.
    Singhal, Sunil
    JOURNAL OF BIOMEDICAL OPTICS, 2021, 26 (05)
  • [33] Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials
    Ellingson, Benjamin M.
    Brown, Matthew S.
    Boxerman, Jerrold L.
    Gerstner, Elizabeth R.
    Kaufmann, Timothy J.
    Cole, Patricia E.
    Bacha, Jeffrey A.
    Leung, David
    Barone, Amy
    Colman, Howard
    van den Bent, Martin J.
    Wen, Patrick Y.
    Yung, W. K. Alfred
    Cloughesy, Timothy F.
    Goldin, Jonathan G.
    NEURO-ONCOLOGY, 2021, 23 (02) : 189 - 198
  • [34] What Is Ailing Oncology Clinical Trials? Can We Fix Them?
    Mittal, Abhenil
    Moore, Sara
    Navani, Vishal
    Jiang, Di Maria
    Stewart, David J.
    Liu, Geoffrey
    Wheatley-Price, Paul
    CURRENT ONCOLOGY, 2024, 31 (07) : 3738 - 3751
  • [35] State of clinical trials in the field of oncology in Turkey
    Nayir, Erdinc
    Ata, Alper
    Erdogdu, Suleyman
    Arican, Ali
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2014, 29 (04): : 181 - +
  • [36] Delayed publication of clinical trials in gynecologic oncology
    Salinaro, Julia R.
    Rossi, Emma C.
    Penvose, Katherine N.
    Zhang, Yingao
    Darling, Alice J.
    GYNECOLOGIC ONCOLOGY, 2024, 183 : 74 - 77
  • [37] Discontinuation and nonpublication of clinical trials in orthopaedic oncology
    Singh, Gurbinder
    Wague, Aboubacar
    Arora, Ayush
    Rao, Varun
    Ward, Derek
    Barry, Jeffrey
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01)
  • [38] Inclusion of elderly patients in oncology clinical trials
    Le Saux, O.
    Falandry, C.
    Gan, H. K.
    You, B.
    Freyer, G.
    Peron, J.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1799 - 1804
  • [39] The Role of Oncology Nurses in Discussing Clinical Trials
    Flocke, Susan A.
    Antognoli, Elizabeth
    Daly, Barbara J.
    Jackson, Brigid
    Fulton, Sarah E.
    Liu, Tasnuva M.
    Surdam, Jessica
    Manne, Sharon
    Meropol, Neal J.
    ONCOLOGY NURSING FORUM, 2017, 44 (05) : 547 - +
  • [40] Diversity and transparency in gynecologic oncology clinical trials
    de Oca, Mary Katherine Montes
    Howell, Elizabeth P.
    Spinosa, Daniel
    Knochenhauer, Hope
    Peipert, Benjamin J.
    Severson, Eric
    Ramkissoon, Shakti
    Akinyemiju, Tomi F.
    Previs, Rebecca A.
    CANCER CAUSES & CONTROL, 2023, 34 (02) : 133 - 140